Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel-Reference-Cited by-同舟云学术

Updated Treatment Recommendation on Use of Cabotegravir and Rilpivirine for People With HIV From the IAS-USA Guidelines Panel

Published:2024-03-26 Issue:12 Volume:331 Page:1060
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Sax Paul E.¹,Thompson Melanie A.²,Saag Michael S.³,

Affiliation:

1. Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

2. AIDS Research Consortium of Atlanta, Atlanta, Georgia

3. School of Medicine, University of Alabama at Birmingham

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2816037/jama_sax_2024_le_240034_1710443228.05534.pdf

Reference6 articles.

1. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA Panel.;Gandhi;JAMA,2023

2. First demonstration project of long-acting injectable antiretroviral therapy for persons with and without detectable HIV viremia in an urban HIV clinic.;Christopoulos;Clin Infect Dis,2022

3. Demonstration project of long-acting antiretroviral therapy in a diverse population of people with HIV.;Gandhi;Ann Intern Med,2023

4. Long-acting injectable cabotegravir/rilpivirine effective in a small patient cohort with virologic failure on oral antiretroviral therapy.;Brock;Clin Infect Dis,2023;

5. Projected benefits of long-acting antiretroviral therapy in nonsuppressed people with human immunodeficiency virus experiencing adherence barriers.;Chen;Open Forum Infect Dis,2023

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching Human Immunodeficiency Virus Therapy;Infectious Disease Clinics of North America;2024-09

2. Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system;Implementation Science Communications;2024-08-29

3. A6 HIV Subtype in a Pharmacist-Directed Cabotegravir/Rilpivirine Screening Protocol;AIDS Patient Care and STDs;2024-08-22

4. The long wait for long-acting HIV prevention and treatment formulations;The Lancet HIV;2024-08

5. Adolescents and young adults with HIV and unsuppressed viral load: where do we go from here?;Current Opinion in HIV and AIDS;2024-07-30